Menu Search
Equities

BPH Global Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
USZ0:FRA

BPH Global Ltd

Actions
  • Price (EUR)0.0005
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change0.00%
  • Beta-1.1023
Data delayed at least 15 minutes, as of Feb 11 2026 07:07 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

BPH Global Limited is an Australia-based plant-focused biotechnology company. The Company is focused on producing foods, health and cosmetic products which deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research and development, production and commercialization of TCM products, including raw bird’s nest and processed bird’s nest products, raw seaweed and sea plants as sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients extracted from seaweed and sea plants for utilization in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The Company’s product focus is on raw bird’s nests; higher end processed bird’s nest products; and Sea Grapes (Caulerpa Lentillifera) and seaweeds. Its subsidiaries include Hainan SCU Biotechnology Co Ltd, Foshan Gedishi Biotechnology Co Ltd, SCU Lab Pty Ltd, PT BPH Global Indonesia, Stemcell United Pte Ltd and others.

  • Revenue in AUD (TTM)352.38k
  • Net income in AUD-1.49m
  • Incorporated1984
  • Employees31.00
  • Location
    BPH Global LtdBlock ArcadeOffice 324, Level 3, 96 Elizabeth St,MELBOURNE 3000AustraliaAUS
  • Phone+61 28072-1400
  • Fax+61 28072-1400
  • Websitehttps://scu.com.sg/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.